GlassScriptPhysician profile
Robert Matthew Paton
NPI 1295708881
$911.73
in general payments reported to CMS, 2019-2025
19 companies · $100 in 2025
The $100 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $96.04 · 2021: $138 · 2022: $178 · 2023: $77.41 · 2024: $120 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $119.74 | 2021-2025 | Azstarys |
| Kaleo, INC. | $90.11 | 2021-2022 | |
| Glaxosmithkline, LLC. | $85.65 | 2019 | |
| Pfizer INC. | $74.81 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $72.44 | 2019-2023 | Vaxneuvance, Gardasil 9 |
| Ironshore Pharmaceuticals INC. | $66.92 | 2019-2024 | |
| Cranial Technologies, INC | $64.10 | 2022-2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $55.50 | 2020-2022 | |
| Tris Pharma INC | $46.69 | 2020-2025 | Dyanavel Xr |
| Verrica Pharmaceuticals INC. | $37.24 | 2024 | Ycanth |
| Adlon Therapeutics L.P. | $35.28 | 2019-2021 | |
| Sanofi Pasteur INC. | $31.35 | 2022-2023 | |
| Neos Therapeutics, LP | $29.90 | 2020-2022 | |
| Noven Therapeutics, LLC | $23.62 | 2024 | Xelstrym |
| Collegium Pharmaceutical, INC. | $21.35 | 2025 | Jornay Pm |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $17.63 | 2025 | Neffy |
| Vertical Pharmaceuticals, LLC | $13.72 | 2019 | |
| Promius Pharma LLC | $13.14 | 2019 | |
| Nestle Healthcare Nutrition INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Paton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.